Showing results (111-120 of 142) with videos related to
Sort By:
Pageof 15
Cancer Research|November 15, 1994
Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermineC W Porter, B Ganis, Y Rustum, et al.The Biochemical Journal|April 15, 1989
Cellular characterization of a new irreversible inhibitor of S-adenosylmethionine decarboxylase and its use in determining the relative abilities of individual polyamines to sustain growth and viability of L1210 cellsD L Kramer, R M Khomutov, Y V Bukin, et al.Molecular Pharmacology|April 1, 1991
Selective cellular depletion of mitochondrial DNA by the polyamine analog N1,N12-bis(ethyl)spermine and its relationship to polyamine structure and functionP M Vertino, T A Beerman, E J Kelly, et al.Journal of Medicinal Chemistry|May 1, 1989
Synthesis and antiproliferative effects of novel 5'-fluorinated analogues of 5'-deoxy-5'-(methylthio)adenosineJ R Sufrin, A J Spiess, D L Kramer, et al.The Journal of Biological Chemistry|December 1, 1995
Photoaffinity labeling of a cell surface polyamine binding proteinD M Felschow, J MacDiarmid, T Bardos, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1984
Serum thyroglobulin, a monitor of differentiated thyroid carcinoma in patients receiving thyroid hormone suppression therapy: concise communicationW H Blahd, M V Drickman, C W Porter, et al.Cancer Research|May 1, 1985
Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cellsC W Porter, P F Cavanaugh, N Stolowich, et al.Cancer Research|October 16, 1999
The polyamine oxidase inhibitor MDL-72,527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effectsH Dai, D L Kramer, C Yang, et al.Cancer Research|December 1, 1986
Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzymeC W Porter, B Ganis, T Vinson, et al.Environmental Health Perspectives|March 17, 2001
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerationsD C Dorman, S L Allen, J Z Byczkowski, et al.Pageof 15